🟢 BeyondSpring is trading at 5.5% up in pre-market with no confirmed catalyst

BeyondSpring is trading 5.5% higher at $0.83 in pre-market on October 5, with no confirmed catalyst identified. - The prior close was $0.79 on October 2. - On September 29, BeyondSpring reported an FDA Fast Track designation and trial-funding transaction, and disclosed a Nasdaq market-value deficiency notice and an at-the-market share-sale program. - Major U.S. indices were slightly lower. Recent share-price volatility and the Nasdaq compliance issue are relevant background, but are not established causes of the move.